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Diabetes self-care plays a vital role in achieving better diabetes outcomes. To enhance diabetes 
self-care, the strategies of goal setting and barrier identification are widely used to assist people 
in making behavior change. Depression is a common co-morbidity and a barrier to self-care in 
people with diabetes. The purpose of this study was to examine the effects of depression and 
antidepressant use on goal setting and barrier identification in patients with type 2 diabetes. 
In patients with type 2 diabetes enrolled in the American Association of Diabetes 
Educators (AADE) Outcomes System as part of their routine diabetes education, 778 patients 
were included into this analysis. Self-report depression, 7 self-identified behavior change goals, 
and 13 barriers to diabetes self-care were collected from the Diabetes Self-management 
Assessment Report Tool (D-SMART®); antidepressant use was determined from the Diabetes 
Educator Tool (D-ET®). Multiple linear regression was used for the number of goals and the 
number of barriers with controls for relevant covariates. 
Patients with and without depression had a similar number of self-identified behavior 
change goals (P = 0.47), whereas patients with depression had 1.01 barriers to diabetes self-care 
greater than those without depression (P = 0.0001). In the depressed subgroup, there was no 
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significant difference between those with and without antidepressant use in the number of goals 
(model 3A, P = 0.18; model 3B, P = 0.35) and in the number of barriers (P = 0.99).  
Since depression was related to a greater number of barriers to self-care, depression 
screening is important in patients with diabetes. Although antidepressant use had no association 
with the number of goals or the number of barriers, antidepressants are still useful in treating 
depression in patients with diabetes. In addition, collaborative treatment should be integrated to 
provide maximal benefit to improve both diabetes and depression. These conclusions are of 
public health significance and can be used to develop behavior change strategies to improve 
diabetes self-care. 
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1.0  INTRODUCTION 
1.1 DIABETES 
Diabetes is the seventh leading cause of death reported on U.S. death certificates in 2006.1 The 
Centers for Disease Control and Prevention (CDC) estimates that 7.8% of the U.S. population 
(nearly 23.6 million people) suffered from diabetes in 2007.1 While an estimated 17.9 million 
people are diagnosed with diabetes, 5.7 million people (nearly one quarter) are unaware that they 
have the disease.1 
Diabetes is marked by high levels of blood glucose resulting from a shortage of insulin or 
a decreased ability to use insulin. Diabetes can lead to serious complications, such as 
cardiovascular disease, kidney disease, nerve damage, and blindness. People with diabetes also 
have higher premature mortality along with reduced life expectancy by 7-7.5 years.2 In order to 
prevent these complications, achieving adequate control of risk factors is important. 
1.2 DIABETES SELF-CARE 
Diabetes self-care behaviors play a vital role in achieving optimal glycemic control, retarding the 
progression of complications, and decreasing morbidity and mortality associated with diabetes.3-6 
Defined by American Association of Diabetes Educators (AADE), self-care behaviors are 
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healthy eating, being active, monitoring blood glucose, taking medication, problem solving, risk 
reduction activities, and healthy coping. There are known as AADE7 Self-Care Behaviors.7 A 
previous study8 showed that 95% of the routine daily care essential for maintaining glucose 
control needs to be provided by the diabetes patient, demonstrating the necessity for good 
diabetes self-care. According to a recent survey of US nurses and physicians9, promotion of 
effective self-care behaviors is also regarded as one of five key goals that need to be 
accomplished to improve diabetes outcomes. 
1.3 GOAL SETTING AND BARRIER IDENTIFICATION 
To improve diabetes self-care behaviors, the strategies of goal setting and barrier identification 
are widely used to assist people in making behavior change.10-12 Goal setting is a collaborative 
process in which the patient is an active participant in deciding their own diabetes regimens.11 
This method may help people to improve recall of daily demands of diabetes and motivate them 
to participate in diabetes self-care. People with diabetes usually identify diabetes self-care goals 
as linked to their life goals, such as longevity, spending time with family, and maintaining 
independence.13, 14 Factors influencing diabetes self-care goals include health care providers, 
family, and ancillary and outside resources.13, 14  In addition, Estabrooks et al.15 found that 
diabetes patients who were involved in selecting goals for diabetes self-care often selected the 
goals for which they needed to make the most change. For instance, those selecting a goal to 
increase physical activity were significantly less active at baseline than those choosing a goal to 
decrease fat consumption or to increase fruit and vegetable consumption.15 People who 
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participate in the goal-setting process are more likely to overcome potential barriers to self-care 
and to achieve favorable diabetes outcomes.11, 14-18 (See Table 1 and Table 2) 
Barrier identification also minimizes adverse effects on adherence to self-care 
behaviors.19 Most diabetes patients encounter barriers to self-care and these barriers are a major 
challenge when they deal with daily demands of diabetes.20-22 The most frequently reported 
barriers to diabetes self-care include cost, time constraints, inconvenience, low self-efficacy, 
limited coping skills and knowledge, reduced quality-of-life, complications and functional 
disabilities, inadequate resources, limited social and family support, complex regimen, poor 
patient–provider relationship, invasive characteristic for glucose monitoring, and depression or 
distress.13, 23-28 Diabetes patients with multiple barriers are also likely to reduce adherence to 
diabetes self-care.26, 29 (See Table 3 and Table 4) 
1.4 DEPRESSION AND DIABETES 
Depression is a common co-morbidity and a barrier to diabetes self-care in people with diabetes 
mellitus.30 The risk of depression is 50–100% higher in people with diabetes compared to the 
general population.31 People with diabetes not only need to continuously pay attention to their 
complex regimens, but also have the fear of hypoglycemia and diabetes complications. These 
reasons can increase perceived stress, leading to high rates of depression.32 In addition, because 
of loss of energy and motivation, negative cognition, pessimistic attributional style, and passive 
coping strategies,33 people with depression are less likely than those without depression to 
optimally manage their diabetes. 
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For people with diabetes, depression is associated with poor glycemic control, leading to 
more complications,34 higher mortality rates,35 and greater health care costs.36 Depression is also 
related to poor adherence to diabetes self-care. Most studies show that diabetes patients with 
depression are more likely than those without depression to have an unhealthy diet37-41 and low 
medication adherence,37, 39-43 while those with and without depression are similar in compliance 
with glucose monitoring37-41 and with foot care.39, 41 There are inconsistent findings regarding the 
association between depression and exercise.37-41 To clarify the relationships between depression, 
poor diabetes self-care, and adverse diabetes outcomes, McKellar et al.44 used structural equation 
models to find that depression increased symptoms of poor glucose control through lowering 
adherence to diabetes self-care. Accordingly, if these people receive appropriate depression 
treatment, they may improve diabetes outcomes by increasing adherence to diabetes self-care. 
(See Table 5 and Table 6) 
1.5 DEPRESSION TREATMENT AND DIABETES 
Several randomized controlled trials evaluated the effects of depression treatment 
(antidepressants, behavior therapies, or both) in people with diabetes and depression.45-50 Most 
studies found a significant improvement in depression for those receiving antidepressants and/or 
behavior therapies, while effects of depression treatment on glycemic control have been mixed.45, 
47-50 In addition to effects on depression and glycemic control, four studies46, 48-50 investigated the 
association between enhanced depression treatment (antidepressants, behavior therapies, or both) 
and diabetes self-care. Among those with type 2 diabetes and major depression, people receiving 
cognitive behavior therapy plus diabetes education had reduced adherence to self-monitoring of 
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blood glucose compared to those receiving diabetes education alone during the 10-week 
treatment period.49 In a study of older people with diabetes and depression, the intervention 
(including antidepressants and behavior therapies) increased people’s physical activity but had 
no effects on other self-care behaviors (diet, diabetes medication, glucose monitoring, and foot 
inspection) relative to usual care during the 12-month intervention period.50  In another 12-month 
trial comparing collaborative depression treatment (antidepressants and/or behavior therapies) 
with usual care among people with diabetes and depression, the two groups reported no 
difference in diabetes self-care (diet, exercise, smoking, and medication adherence to lipid-
lowering and antihypertensive medicines) except a higher rate of non-adherence to oral 
hypoglycemic agents in intervention group.46 A trial comparing nortriptyline with placebo in 
people with poorly controlled diabetes also showed no effects on compliance with glucose 
monitoring and with medication regimen over the 8-week treatment period.48 From these studies, 
the relationship between treatment of depression and diabetes self-care seems to be inconsistent, 
and only one study48 specifically investigated the effects of antidepressant on diabetes self-care. 
(See Table 7 and Table 8) 
1.6 PURPOSE OF THE STUDY 
Diabetes self-care is not a small task from a patient’s perspective. Depression increases 
difficulties in achieving good diabetes self-care. Although a number of studies37-43 investigated 
the association between depression and diabetes self-care behaviors, there is no literature 
addressing the effects of depression on goal setting and barrier identification in people with 
diabetes. There is only one study to the best of our knowledge examining the effects of 
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depression on goal achievement for control of glucose, lipids, and blood pressure,51 rather than 
on goal setting for adherence to diabetes self-care behaviors. Moreover, whether goal setting and 
barrier identification are improved by alleviated depression due to antidepressant use is still 
unanswered. Therefore, our first study aim is to evaluate the effects of depression on the number 
of self-identified behavior change goals and the number of barriers to diabetes self-care among 
patients with type 2 diabetes. Our second aim is to study the treatment effects of antidepressants 
on the number of self-identified behavior change goals and the number of barriers to diabetes 
self-care in the depressed subgroup. 
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2.0  METHODS 
2.1 STUDY SETTING 
This analysis was conducted using data from AADE Outcomes System, which was developed to 
facilitate the delivery, documentation, and evaluation of patient behavior change in the provision 
of diabetes self-management education (DSME).7 The AADE Outcomes System was integrated 
into Internet, touch-screen, and telephonic systems within 8 sites in the Pittsburgh Regional 
Initiative for Diabetes Education (PRIDE) network.10 PRIDE is a regional health care 
collaboration established by the University of Pittsburgh Diabetes Institute to improve diabetes 
education and care in western Pennsylvania.52 Patients with type 1 or type 2 diabetes were 
enrolled in the system as part of their routine diabetes education visits from 2005 to 2008. To be 
eligible for this study, complete data in the following fields were needed: self-report depression, 
antidepressant use, self-identified behavior change goals, and barriers to diabetes self-care. Also, 
only patients with type 2 diabetes were included. Therefore, final sample size was 778 (Figure 
1). This study was approved by the Institutional Review Boards of the University of Pittsburgh. 
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2.2 MEASUREMENT 
Two instruments were developed to collect data from patients (the Diabetes Self-management 
Assessment Report Tool, D-SMART®) and from diabetes educators (the Diabetes Educator 
Tool, D-ET®).10 The D-SMART is a self-report instrument that gathers information about (1) 
demographics and health history and (2) behaviors and behavior change goals, organized in 
terms of the domains of the AADE7 Self-Care Behaviors.10 Patients were asked to complete a 
baseline D-SMART prior to the start of DSME program. The D-ET was completed by the 
diabetes educator during the provision of DSME, and provided an opportunity for the educator to 
record medical information about the patient and the educator’s assessment of the patient’s needs 
and progress. In the present study, self-report depression, 7 self-identified behavior change goals, 
and 13 barriers to self-care were collected from the D-SMART®; antidepressant use was 
determined from the D-ET®. Demographic (age, gender, race, education status, smoking, 
alcohol drinking, family history of diabetes, diabetes duration, and diabetes education) and 
clinical (BMI, HbA1c, complications, and insulin use) data were obtained from either the D-
SMART or the D-ET. 
Depression status was identified if patients reported “Depression or anxiety” in D-
SMART or had records of antidepressant use in D-ET.41 To determine self-identified behavior 
change goals, patients chose the domains in which they would like to make changes including 
activity, eating, medication taking, monitoring, problem solving for blood sugars and sick days, 
reducing risks of diabetes complications, and living with diabetes. Patients also identified the 
level of each barrier that kept them from making the change. Among the four levels of each 
barrier to self-care, patients answering “A lot ”, “some”, “a little” were categorized as those who 
had barriers; patients answering “Not at all” were categorized as those who did not have barriers. 
9 
2.3 STATISTICAL ANALYSIS 
Demographic and clinical data were reported using measures of central tendency (percentage or 
mean/medium). Comparisons between patients with and without depression or with and without 
antidepressant use were performed using the χ2 test for categorical variables. Continuous 
variables were analyzed using the Student t or Wilcoxon rank sum test. 
Multiple linear regression was employed for the number of self-identified behavior 
change goals and the number of barriers to self-care. Univariate modeling was performed 
followed by multivariable modeling. Those covariates whose p-values were < 0.10 were 
considered for multivariable models. Covariates for consideration included: depression status 
(Y/N), antidepressant use (Y/N), age (continuous), gender, race (white/black/others), education 
status (did not finish high school/high school/some college or greater), BMI (continuous), 
smoking (never/former/current), alcohol drinking (Y/N), family history of diabetes (Y/N), 
diabetes duration (continuous), diabetes education (Y/N), the number of diabetes complications 
(continuous), HbA1c level (continuous), insulin use (Y/N), and the number of barriers (7-13/0-
6). Transformation of covariates was performed where necessary.  P-values < 0.05 were 
considered significant. All analysis was completed using SAS 9.2. (SAS Institute Inc., Cary, 
North Carolina) 
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3.0  RESULTS 
3.1 COMPARISONS BETWEEN PATIENTS INCLUDED AND EXCLUDED 
Upon examination of those excluded from this analysis, we found that patients included were 
more likely to be white people with higher BMI, less alcohol drinking, family history of diabetes, 
insulin prescriptions, longer duration of diabetes, and more diabetes complications. There was no 
significant difference between patients included and excluded in depression status, age, gender, 
education status, smoking, diabetes education, and HbA1c level. (See Appendix A) 
3.2 DEMOGRAPHIC AND CLINICAL CHARACTERISTICS 
Demographic and clinical characteristics of patients by depression/antidepressant status (ie. non-
depressed patients, depressed patients with antidepressant, and depressed patients without 
antidepressant) are shown in Table 9. Between patients with and without depression, depressed 
patients were more likely to be younger (56 vs. 60 yr), obese (34.38 vs. 33.16 kg/m2), female 
(71.96% vs. 55.03%), currently smoking (28.51% vs. 18.25%), to have more diabetes 
complications, and to suffer from kidney or bladder problems, numbness or pain, and vision 
problems, while they were less likely to drink alcohol (20.37% vs. 26.64%). Race, education 
status, family history of diabetes, duration of diabetes, diabetes education, HbA1c level, insulin 
11 
use, and the prevalence of some complications (such as high blood pressure, stroke, heart disease 
or chest pain, and problems with sexual function) were similar in patients with and without 
depression. Between patients with and without antidepressant use in the depressed subgroup, 
they were similar in most demographic and clinical characteristics except that those with 
antidepressant use were younger (55 vs. 57 yr) and were more likely to have diabetes education 
(29.44% vs. 14.44%) than those without antidepressant use. 
3.3 UNADJUSTED SELF-IDENTIFIED BEHAVIOR CHANGE GOALS AND 
UNADJUSTED BARRIERS TO DIABETES SELF-CARE 
By depression/antidepressant status, unadjusted self-identified behavior change goals and 
unadjusted barriers to diabetes self-care are presented in Table 10 and Table 11, respectively. 
Patients with and without depression were similar in the number of self-identified behavior 
change goals (P = 0.11). In the depressed subgroup, patients with and without antidepressant use 
were also similar in the number of goals (P = 0.26). For barriers to diabetes self-care, patients 
with depression had a greater number of barriers to self-care compared to those without 
depression (7 vs. 6, P < .0001), whereas in the depressed subgroup, patients with and without 
antidepressant use were similar in the number of barriers (P = 0.75). 
12 
3.4 LINEAR REGRESSION MODELS 
Multiple linear regression was used to evaluate the effects of depression or antidepressant use on 
the number of goals or the number of barriers with controls for relevant covariates (Table 12). 
From the model 1, depression had no association with the number of goals after adjusting for 
age, race, education, and the number of barriers (P = 0.47). Patients who were young (P < .0001), 
white (black, P = 0.02; others, P = 0.01), educated (did not finish high school, P < .0001; high 
school diploma, P = 0.0002), and had a greater number of barriers (P = 0.03) were more likely to 
have a greater number of goals. From the model 2, patients with depression had 1.01 barriers 
greater than those without depression after controlling for BMI, race, education, age, and insulin 
prescription (P = 0.0001). Patients with a greater number of barriers were more likely to have 
higher BMI (P < .0001), to be black or other race (black, P = 0.05; others, P = 0.006), to have 
lower education (did not finish high school, P = 0.01; high school diploma, P = 0.11), and to 
have insulin prescription (P < .0001). From the model 3A, there was no relation between 
antidepressant use and the number of goals in the depressed subgroup after adjusting for age, 
race, education, insulin prescription, and family history of diabetes (P = 0.18). In the depressed 
subgroup, patients who were white people (black, P = 0.04; others, P = 0.001), had higher 
education (did not finish high school, P = 0.05; high school diploma, P = 0.13), did not use 
insulin (P = 0.07), and had family history of diabetes (P = 0.06) were more likely to have a 
greater number of goals. After excluding those covariates with borderline P value (such as 
education, insulin use, and family history of diabetes) (the model 3B), antidepressant use was 
still not significantly related to the number of goals after adjusting for age and race (P = 0.35). 
According to this model, white people (black, P = 0.05; others, P = 0.003) with younger age (P = 
0.02) were more likely to have a greater number of goals in the depressed subgroup. From the 
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model 4, we found that depressed patients with and without antidepressants were similar in the 
number of barriers after controlling for age, BMI, education, and insulin use (P = 0.99). Patients 
with a greater number of barriers were more likely to have higher BMI (P = 0.0003), to have 
lower education (did not finish high school, P = 0.04; high school diploma, P = 0.24), and to use 
insulin (P = 0.004). The main findings remained the same even though additionally including 
HbA1c level, insulin use, or both as covariates in each model. 
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4.0  DISCUSSION 
4.1 SUMMARY OF FINDINGS 
In patients with type 2 diabetes enrolled in the AADE Outcomes System as part of their routine 
diabetes education, those with and without depression had a similar number of self-identified 
behavior change goals, whereas patients with depression had 1.01 barriers to diabetes self-care 
greater than those without depression. In the depressed subgroup, antidepressant use had no 
association with the number of goals they set and the number of barriers they identified. 
4.2 SIGNIFICANCE OF THE STUDY 
Goal setting and barrier identification play important roles in helping patients make behavior 
change and achieve better diabetes self-care ultimately. Depression is not only a common co-
morbidity in patients with diabetes, but also a well-known barrier that affects diabetes self-care. 
Although several studies show negative effects of depression on diabetes self-care37-43, whether 
depression has influences on goal setting and barrier identification has not been well-studied. 
The available study investigated the effects of depression on goal achievement for clinical 
outcomes,51 rather than on goal setting for diabetes self-care. A number of studies explored 
barriers in patients with diabetes,13, 25-28 rather than evaluated the effects of depression on 
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patients’ barriers to diabetes self-care. Thus, our study is unique and provides important 
information for diabetes educators to help patients with diabetes and depression. 
4.3 POSSIBLE EXPLANATIONS 
Beyond our expectation that patients with depression have decreased interest in making behavior 
change due to associated characteristics (such as pessimism and fatigue), we found that there was 
no association between depression and the number of self-identified behavior change goals. One 
possible explanation is that the patient in our study was those who received routine diabetes 
education, and therefore these patients were more active to pursue intensive treatments to 
achieve better diabetes outcomes. This impetus to seek help to improve their disease may 
compromise their negative behavioral style, leading to the absence of an effect of depression on 
their goal setting. 
Our study showed that patients with depression had a greater number of barriers to 
diabetes self-care than those without depression. However, there was no difference between 
those with and without antidepressant use in the depressed subgroup. This result is similar to 
previous findings that the treatment of depression (antidepressants and/or behavior therapies) had 
no effects on diabetes self-care behaviors (specifically, nutritional recommendations, smoking 
cessation, and foot care).46, 48-50 Thus, these findings suggest that the treatment of depression 
alone may be not enough to address patients’ barriers for them to achieve better diabetes self-
care. Overcoming patients’ barriers to diabetes self-care may require intensive interventions 
specific to each barrier. Another possibility is that complex diabetes regimens may reduce 
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patients’ adherence to antidepressants46, 50, leading to equal performance between patients with 
and without antidepressants. 
4.4 LIMITATIONS 
Our study has some limitations that warrant consideration. First, this study is cross-sectional, and 
therefore the temporal association cannot be established. For instance, we cannot determine 
whether depression increases the number of barriers to diabetes self-care, or a greater number of 
barriers to diabetes self-care make patients feel depressed, or both. Thus, future longitudinal 
studies are needed to examine all the cause-effect relationships in this study. Second, the goal 
setting and barrier identification were determined by patients in the D-SMART. Since there were 
7 domains in goal setting and 13 items in barrier identification, some patients may feel burdened 
by completing all the questions and may not answer all questions for goal setting and barrier 
identification. Thus, among 1575 patients with type 2 diabetes in this system, 442 (28.06%) 
patients had missing data in goal setting and 428 (27.17%) patients in barrier identification. 
Furthermore, those who were excluded from this study due to missing values were different from 
those who were included in some demographic and clinical characteristics (such as race, BMI, 
alcohol drinking, family history of diabetes, insulin use, diabetes duration, and complications), 
which may restrict the generalizability of the results. Third, to identify those with depression, we 
relied on patients’ self-report in D-SMART and their records of antidepressant use in D-ET. 
Since some patients may not reveal their depression tendency and not all depressed patients need 
to take antidepressants, the identification of depression on the basis of self-report and 
antidepressant use may underestimate the number of patients with depression. This 
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misclassification bias may account for inability to detect significant differences. To avoid this 
bias, structured interviews are preferred in future studies to make a diagnosis of major 
depression. In addition, formal psychiatric assessment is considered to be the gold standard in 
identifying depressed patients. Forth, the record of antidepressant use was obtained from the 
diabetes educator during the provision of DSME. However, the medication data indicated only 
medicines the patient prescribed, not medicines they actually took. Thus, the objective 
measurement (e.g., electronic monitoring caps43) is needed to monitor medication adherence in 
future studies. Fifth, some antidepressants are not only used to treat depression, but also taken to 
relieve other disorders. For example, duloxetine, a selective serotonin and norepinephrine 
reuptake inhibitor, is not only regarded as an antidepressant, but also wildly used to inhibit pain 
due to diabetic peripheral neuropathy. In our study, only 13 (2%) patients had records of 
duloxetine, and therefore this was not likely to affect our results. 
4.5 FUTURE STUDIES 
Based on our findings, patients with depression had about one barrier greater than those without 
depression. Although this difference between those with and without depression in the number of 
barriers is small, whether it may bring about significant influences on diabetes self-care is 
unanswered. It is possible that depressed patients are likely to have a certain item of barriers to 
diabetes self-care, and therefore they are likely to have poor adherence to the related domains of 
diabetes self-care. Thus, in future studies, it is necessary to examine the effects of depression on 
each item of barriers and also to evaluate the clinical significance of these effects on diabetes 
self-care. 
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Goal setting, skill acquisition, and maintenance of motivation are important components 
for diabetes patients to achieve successful self-care.53, 54 It is well-known that depression is 
related to poor diabetes self-care.37-43 In our study, we found that patients with and without 
depression had a similar number of self-identified behavior change goals. To confirm that 
patients with and without depression are similar in goal setting, investigating the effects of 
depression on identifying each domain of behavior change goals is needed. If patients with and 
without depression do perform similarly in goal setting, it suggests that depressed patients may 
have some problems to acquire coping skill or to maintain motivation so that they are less likely 
to have better diabetes self-care. Thus, exploring the factors that affect depressed patients in 
coping skill and maintenance of motivation is important in future studies. 
4.6 PUBLIC HEALTH SIGNIFICANCE 
Since depression was related to an increased number of barriers to diabetes self-care, depression 
screening is important in patients with diabetes. If depressed patients can be identified in the 
early stages, intensive interventions can be applied earlier to help them overcome potential 
barriers and then achieve better diabetes self-care. Although antidepressant use had no 
association with the number of goals or the number of barriers, it does not indicate that 
antidepressants are not useful in patients with diabetes and depression. Antidepressant use is still 
important in treating depression for patients with diabetes and depression.48 Additionally, 
effective diabetes treatment may be compromised by depression-related characteristics (e.g., 
hopeless), while effective depression treatment may be diminished by diabetes complications 
(e.g., pain). Thus, collaborative treatment should be integrated to provide maximal benefit to 
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improve both diabetes and depression, and also to avoid adverse influences of one disease 
resulted from the treatment of the other disease. 
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5.0  TABLES AND FIGURE 
Table 1: Characteristics of studies investigating goals in people with diabetes 
AUTHOR 
STUDY 
DESIGN 
STUDY AIM POPULATION 
SAMPLE 
SIZE 
METHODS/MEASUREMENTS 
Rush WA et 
al. (2008)51 
Prospective 
cohort study 
To examine whether depressive 
symptoms are associated with 
achievement of recommended goals 
for control of glucose, lipids, and 
blood pressure among patients with 
diabetes. 
Inclusion: type 1 or type 2 
diabetes, and ≥ 18 y/o 
Exclusion
1223 
subjects 
: those without 
pharmacy coverage 
Depression 
• Survey at baseline 
• Self-reported  
• 2 questions from the PHQ-2 screening tool  
Goals for HbA1c (≤ 7.0), LDL (≤ 100), SBP (≤ 130), 
and DBP (≤ 80) 
• Medical record 
• 1-year period after the survey 
Morrow AS et 
al. (2008)13 
Cross-
sectional study 
To investigate the life and health 
goals of older adults with diabetes, 
and explore the factors that influence 
their diabetes self-management. 
Inclusion 24 subjects : type 2 diabetes, ≥ 
55 y/o, hypertension, and at 
least one other chronic 
comorbidity 
Qualitative in-depth interviews 
• Prior to the interview, information about the 
patient’s medical history, ability to perform 
activities of daily living, and demographic 
characteristics was collected using questionnaires 
administered by investigators.  
• Health care goals, effects of diabetes and other 
chronic conditions on daily life, self-management 
practices, and communication with health care 
providers were asked using interview guide. 
Ismail K et al. 
(2008)55 
Randomized 
controlled trial 
To determine whether motivational 
enhancement therapy with or without 
cognitive behavior therapy improves 
glycemic control in type 1 diabetes 
compared with usual care. 
Inclusion 344 subjects : type 1 diabetes for ≥ 
2 years, with HbA1c levels of 
8.2% ~ 15%, and without 
complications or severe 
comorbid disease. 
HbA1c (primary outcome) 
Depression (secondary outcomes) 
• Self-report 
• Patient Health Questionnaire-9 (score range, 0 to 
27; scores ≥ 10 represent major depressive 
disorder) 
Diet, exercise, and blood sugar testing (secondary 
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outcomes) 
• Revised Summary of Diabetes Self-Care 
• Days in the last 7 days the participant engaged in 
self-care (score range, 0 to 7 days) 
Hypoglycemia (secondary outcomes) 
• Hypoglycemia Fear Survey 
• 10 behavior items (score range, 0 to 40) and 13 
worry items (score range, 0 to 52) self-rated on 5-
point Likert scales. 
 Quality of life (secondary outcomes) 
• Satisfaction and impact subscales of the Diabetes 
• Quality of Life scale (score range per subscale, 1 
to 5) 
Body mass index (secondary outcomes) 
Estabrooks 
PA et al. 
(2005)15 
Randomized 
controlled trial 
To determine the frequency and 
effectiveness of behavioral goal 
choices in the self-management of 
diabetes and to test goal-setting 
theory hypotheses that self-selection 
and behavioral specificity of goals 
are key to enhancing persistence. 
Inclusion 422 subjects : type 2 diabetes, and 
≥ 25 y/o 
Physical activity 
• 11-item Behavioral Risk Factor Surveillance 
System (BRFSS) 
• A brief screener on frequency and duration of 
vigorous and moderate-level activities 
 Dietary fat 
• 17-item Block Dietary Data Systems (BDDS) 
• A brief calculation of the participant’s dietary fat 
Fruits and vegetables intake 
• 7-item BDDS “Fruit/Vegetable Screener” 
• A brief scanner on current number of fruit and 
vegetable portions consumed each day 
Huang ES et 
al. (2005)14 
Qualitative 
study 
To examine how older patients define 
their healthcare goals, what factors 
shape their goals, and the extent to 
which their goals relate to self-care 
behavior. 
Inclusion 28 subjects : type 2 diabetes, and 
≥ 65 y/o 
Semi-structured interviews  
• The questions of the interview guide were 
designed to explore patients’ healthcare goals, 
diabetes mellitus care goals, experiences with 
diabetes mellitus, priorities for self-care strategies, 
and daily self-care tasks 
Rachmani R 
et al. (2005)17 
Randomized 
controlled trial 
To examine whether motivating 
patients to gain expertise and closely 
following their risk parameters will 
attenuate the course of microvascular 
and cardiovascular sequelae of 
diabetes. 
Inclusion: 141 subjects  type 2 diabetes < 10 
yr, 40-70 y/o, BMI ≤ 35 
kg/m2, BP ≥ 140/90 mmHg; 
LDL ≥ 120 mg/dl, serum 
creatinine ≤ 2 mg/dl (176 
µmol/L), albumin/creatinine 
ratio < 200 mg/g; and no 
history of myocardial 
infarction, angina pectoris, 
Cardiovascular parameters (MI, stroke, CABG+PCI, 
Nonfatal CV events, CV mortality, Non-CV mortality) 
• From the letters of the primary care physicians, 
hospital discharge summaries, or other 
consultants’ reports. 
Lab data (HbA1c, SBP, DBP, LDL, GFR, and 
albumin/creatinine) 
 
Table 1: Characteristics of studies investigating goals in people with diabetes (cont.) 
 
22 
vascular surgery, stroke, or 
any systemic or malignant 
disease. 
Olivarius NF 
et al. (2001)18 
Randomized 
controlled trial 
To assess the effect of a multifaceted 
intervention directed at general 
practitioners on six year mortality, 
morbidity, and risk factors of patients 
with newly diagnosed type 2 
diabetes. 
Includion: newly diagnosed 
type 2 diabetes who survived 
until 6 year follow up , and  > 
40 y/o 
 
874 subjects Predefined primary outcomes: overall mortality and 
incidences of diabetic retinopathy, urinary albumin 
concentration >15 mg/l, myocardial infarction, and 
stroke in patients without these outcomes at baseline. 
Secondary outcomes: new peripheral neuropathy, 
angina pectoris, intermittent claudication, and 
amputation.  
Tertiary outcomes: levels of risk factors included in 
patients' goals. 
HbA1c: Glycosylated Hemoglobin 
LDL: Low-Density Lipoprotein 
BP: Blood Pressure 
SBP: Systolic Blood Pressure 
DBP: Diastolic Blood Pressure 
MI: Myocardial Infarction 
CABG: Coronary Artery Bypass Graft 
PCI: Percutaneous Coronary Intervention 
CV: Cardiovascular. 
GFR: Glomerular Filtration rate 
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Table 2: Major findings of studies investigating goals in people with diabetes 
AUTHOR 
MAJOR FINDING(S) / RESULTS (PRIMARILY WITH RESPECT TO 
DEPRESSION) 
STUDY NOVELTY / COMMENTS 
Rush WA et 
al. (2008)51 
• Diabetes patients with depression symptoms were less likely to be at their glucose goal 
(43% vs 50%; P = .0176) but more likely to be at their SBP goal (57% vs 51%; P = 
.0435). 
• The association between lipids and depression symptoms was related to a lower rate for 
low-density lipoprotein testing (56% vs 68%; P < .0001).  
• Treatment with antidepressants resulted in a greater percentage achieving glucose and 
blood pressure goals but not lipid goals. 
• Depression seems to have a variable impact on achieving these 
clinical goals, perhaps because the goals have differing 
measurement logistics and biological profiles. 
• Depression symptoms make it harder to reach glucose goals but 
that treatment with an antidepressant may ameliorate this effect. 
Morrow AS et 
al. (2008)13  
• Primary life and health goals reported by participants: Longevity, spend time with 
family, improve or maintain physical functioning, maintain independence, improve 
diabetes care 
(improve lifestyle (diet, exercise, weight), control sugars, avoid complications) 
• Factors influencing diabetes self-care goals: Health care providers, ancillary and outside 
resources, family, diabetes discordant illnesses, and retirement. 
• Functional capabilities and social support were key factors in the ways that older adults 
described the relationship between self-management of diabetes and their broader goals. 
• Limitation: 1) generalizability 
• The language used to describe health goals was often 
indistinguishable from that used to describe life goals. 
• For goal-setting to be effective, patients and caregivers must feel 
confident in performing the necessary self-management steps and 
must feel that the specific self-management goal is related to 
one’s overall life goals as well. 
Ismail K et 
al. (2008)55 
• In an analysis including all randomly assigned patients, the 12-month change in HbA1c 
levels compared with usual care was -0.46% (95% CI, -0.81% to -0.11%) in the 
motivational enhancement therapy plus cognitive behavior therapy group and -0.19% 
(CI, -0.53% to 0.16%) in the motivational enhancement therapy group alone.  
• There was no evidence of treatment effects on secondary outcomes. 
• Nurse-delivered motivational enhancement therapy and cognitive 
behavior therapy is feasible for adults with poorly controlled type 
1 diabetes. 
Estabrooks 
PA et al.  
(2005)15 
• At baseline, participants who selected goals to increase physical activity, to reduce fat 
consumption, or to increase fruits and vegetables intake were significantly less active, 
consumed more dietary fat, and ate fewer fruits and vegetables, respectively . 
• Participants who selected a reduced-fat goal showed a significantly larger decrease than 
did those who selected a goal for physical activity or for fruits and vegetables.  
• Participants who selected a goal for fruits and vegetables showed significant increase in 
fruits and vegetables consumption.  
• Participants who selected a goal for physical activity demonstrated significant increase 
in days of moderate and vigorous physical activity. 
• When participants are provided with information on health 
behavior status and an option of behavioral goals for managing 
type 2 diabetes, they will select personally appropriate goals, 
resulting in significant behavioral changes over a 6-month period 
Huang ES et 
al. (2005)14 
• The majority of patients expressed their healthcare goals in a social and functional 
language, in contrast to the biomedical language of risk factor control and complication 
prevention, even when specifically asked about goals for diabetes mellitus care.  
• Patient’s predominant healthcare goals centered on maintaining their independence and 
their activities of daily living (71%).  
• Medical experiences of friends and family (50%), social comparison with peers (7%), 
and medical professionals (43%) shaped patients’ goals.  
• Self-reported medication adherence and glucose monitoring was high, but more than 
• Providers could enhance their communication about such medical 
decisions by exploring patients’ specific circumstances and 
reframing diabetes mellitus treatment goals in patients’ own 
language. These may be crucial steps to developing successful 
individualized care plans. 
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Table 2: Major findings of studies investigating goals in people with diabetes (cont.) 
one-quarter of patients failed to adhere to any dietary recommendations, and one-third 
failed to adhere to their exercise regimens. 
Rachmani R 
et al. (2005)17 
• There were 80 cardiovascular events (8 deaths) in the control group versus 47 events (5 
deaths) in the intervention group (P = 0.001). The relative risk (RR) over 8 yr for a 
cardiovascular event in the intervention group versus the control group was 0.65 (95% 
confidence interval, 0.89 to 0.41).  
• There were 17 and 8 cases of stroke in the control and intervention groups, respectively 
(P = 0.05). RR for stroke was 0.47 (95% confidence interval, 0.85 to 0.32).  
• In the control group, 14 patients developed overt nephropathy (4 ESRD) versus 7 (1 
ESRD) in the intervention group (P = 0.05).  
• Throughout the study period, BP, LDL cholesterol, and HbA1c were significantly lower 
in the intervention group than in the control patients.  
• Well informed and motivated patients were more successful in 
obtaining and maintaining good control of their risk factors, 
resulting in reduced cardiovascular risk and slower progression of 
microvascular disease. 
Olivarius NF 
et al. (2001)18 
• Predefined non-fatal outcomes and mortality were the same in both groups.  
• The following risk factor levels were lower for intervention patients than for comparison 
patients (median values): fasting plasma glucose concentration (7.9 vs. 8.7 mmol/l, P = 
0.0007), HbA1c (8.5% vs. 9.0%, P < 0.0001; reference range 5.4-7.4%), systolic blood 
pressure (145 vs. 150 mm Hg, P = 0.0004), and cholesterol concentration (6.0 vs. 6.1 
mmol/l, P = 0.029, adjusted for baseline concentration).  
• Both groups had lost weight since diagnosis (2.6 v 2.0 kg).  
• Metformin was the only drug used more frequently in the intervention group (24% 
(110/459) vs. 15% (61/415)). 
• Intervention doctors arranged more follow up consultations, referred fewer patients to 
diabetes clinics, and set more optimistic goals. 
• In primary care, use of the model (individualised goals with 
educational and surveillance support) may reduce risk factors to a 
level that has been shown to have a beneficial effect on the 
development of diabetic complications without adverse weight 
gain. 
 
HbA1c: Glycosylated Hemoglobin 
LDL: Low-Density Lipoprotein 
BP: Blood Pressure 
SBP: Systolic Blood Pressure 
DBP: Diastolic Blood Pressure 
ESRD: End Stage Renal Disease  
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Table 3: Characteristics of studies investigating barriers to self-care behaviors in people with diabetes 
AUTHOR 
STUDY 
DESIGN 
STUDY AIM POPULATION 
SAMPLE 
SIZE 
MEASUREMENTS 
Vijan S et al. 
(2005)25 
Cross-
sectional study 
To evaluate, both quantitatively and 
qualitatively, barriers to following 
dietary recommendations in people 
with type 2 diabetes 
People were recruited from the 
primary care population of a 
large academic medical centre 
and two VA hospitals. 
Exclusion: 
197 subjects  
those were 
diagnosed with diabetes 
prior to 30 y/o 
Patient attitudes towards hypoglycaemic treatments 
Quantitative phase 
• A mailed, self-administered 50-question survey 
• Ratings of the burden of diabetes therapies on a 
seven-point scale (from 0 = do not dislike at all to 
6 = dislike very much)  
 
Patient views towards diabetes care and barriers to 
follow interventions 
Qualitative phase 
• Six focus group with 6-12 participants in each 
Wagner J et 
al. (2005)26 
Cross-
sectional study 
To test the hypothesis that 
invasiveness is a barrier to SMBG 
Adults with diabetes attending 
the 2002, 2003, and 2004 
American Diabetes 
Association “Diabetes Expos” 
(health fairs) held at 
convention centers of large, 
northeastern cities. 
339 subjects 
(subsample=
32 subjects) 
Anxiety regarding insulin injecting and SMBG 
• The Diabetes Fear of Injecting and Self-Testing 
Questionnaire (D-FIST) 
Hassle/burden regarding SMBG 
• The Diabetes Hassles Scale 
• SMBG routine burden and non-routine burden 
Knowledge about the link between glycemic control 
and long-term vascular complications of diabetes. 
• The Diabetes Heart Disease Facts Questionnaire 
Percentage of SMBG adherence 
• Self-reported No. of SMBG / recommended No. of 
SMBG 
• Meter-recorded No. of SMBG / recommended No. 
of SMBG 
Invasiveness as a barrier to SMBG 
• Measure of Invasiveness as a reason for Skipping 
SMBG (MISS) 
• A higher score on the MISS reflects the tendency 
to miss or skip SMBG because of the invasiveness 
of the procedure. 
Nagelkerk J et 
al. (2006)27 
Cross-
sectional study 
To describe the perceived barriers to 
self-management of adults with type 
2 diabetes in a rural setting and to 
identify effective strategies in self-
management to highlight 
infrastructure needs or changes in 
Inclusion 24 subjects : type 2 diabetes, ≥ 
21 y/o, having a telephone, 
and being able to read, write 
and speak English. 
The focus group interview schedule was developed 
using the key-informant technique, where three 
individuals with a special interest in diabetes were 
interviewed using open-ended questions. Key 
concepts emerged which were included in the focus 
group scheme. 
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clinical practice that would facilitate 
the integration of diabetes self-
management. 
Morrow AS et 
al. (2008)13 
Cross-
sectional study 
To investigate the life and health 
goals of older adults with diabetes, 
and explore the factors that influence 
their diabetes self-management. 
People from outpatient clinics 
in the Houston area 
Inclusion
24 subjects 
: type 2 diabetes, ≥ 
55 y/o, hypertension, and at 
least one other chronic 
comorbidity 
Qualitative in-depth interviews 
• Prior to the interview, information about people’s 
medical history, ability to perform activities of 
daily living, and demographic characteristics was 
collected using questionnaires administered by 
investigators.  
• Health care goals, effects of diabetes and other 
chronic conditions on daily life, self-management 
practices, and communication with health care 
providers were asked using interview guide. 
Daly JM et al. 
(2009)28 
Cross-
sectional study 
To determine (1) which barriers to 
diabetes management were 
associated with the problem 
behaviors and (2) which patient 
behaviors and barriers are associated 
with diabetes control as measured by 
glycosylated hemoglobin (HbA1c). 
People being followed in 
primary care outpatient clinics 
at a midwestern medical 
center  
Inclusion
253 subjects 
: type 2 diabetes, 
regular clinic patients (≥ 2 
outpatient visits within the 
previous 12 months), and 
having HbA1c test within 
the previous 3 months 
Diabetes self-care behaviors and barriers 
• 141 questions in 7 domains 
• Self-report 
• Self-care behaviors were classified in 2 ways: (1) 
percentage of time the people adhered to 
medication, meal plan, exercise, and glucose 
testing plans during the past month, and (2) the 
level of satisfaction with each of the preceding 
domains. From these 2 measures, a combined 
dichotomous adherence-satisfaction score for each 
domain was created. 
• Barriers to each self-care behavior were 
dichotomous. 
• Depressive symptoms were evaluated using self-
reported 9-item Patient Health Questionnaire 
(PHQ-9) 
• Physical and mental health was evaluated using 
12-item Short-Form Health Survey (SF-12) 
HbA1c 
• Chart review  
SMBG: Self-Monitoring of Blood Glucose 
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Table 4: Major findings of studies investigating barriers to self-care behaviors in people with diabetes 
AUTHOR 
MAJOR FINDING(S) / RESULTS (PRIMARILY WITH RESPECT TO 
DEPRESSION) 
STUDY NOVELTY / COMMENTS 
Vijan S et al. 
(2005)25 • Moderate diet was seen as a greater burden than oral agents (median 1 vs. 0, P = 0.001), 
but less of a burden than insulin (median 1 vs. 4, P < 0.001).  
Quantitative phase 
• A strict diet aimed at weight loss was rated as being similarly burdensome to insulin 
(median 4 vs. 4, P = NS). 
• Self-reported adherence was much higher for both pills and insulin than it was for a 
moderate diet. 
• The most commonly identified barrier was the cost (14/14 reviews), followed by small 
portion sizes (13/14 reviews), support and family issues (13/14 reviews), and quality of 
life and lifestyle issues (12/14 reviews). 
Qualitative phase 
• People in the urban site, who were predominantly African-American, noted greater 
difficulties in communicating with their provider about diet and social circumstances, 
and also that the rigid schedule of a diabetes diet was problematic. 
• Limitation: 1) selected populations used, 2) low (54%) response 
rate of survey, and 3) no causal inference due to cross-sectional 
study. 
• Interventions aimed at improving people’s ability to modify their 
diet need to take account of people’s preferences and cultural, 
racial, or economic variation. 
• Treatment guidelines need to consider people’s preferences and 
barriers when setting goals for treatment. 
 
Wagner J et 
al. (2005)26 
• 63% of respondents reported skipping SMBG because of the invasiveness of the 
procedure. 
• MISS scores were negatively related to percent adherence to healthcare provider SMBG 
recommendations as measured by memory function of automated meters (Spearman’s r 
= 0.47, P < 0.01) and absolute SMBG frequency regardless of SMBG recommendations 
(Spearman’s r = 0.11, P < 0.05) 
• MISS scores were positively correlated with SMBG anxiety (Spearman’s r = 0.50, P < 
0.01) even though high anxious participants were deleted (Spearman’s r = 0.28, P < 
0.01). 
• MISS scores were also correlated with the degree to which people find routine and non-
routine SMBG checks a burden (routine r = 0.38, P < 0.01; non-routine r = 0.45, P < 
0.01).  
• Participants with less knowledge about the importance of glycemic control in the 
development of diabetes vascular complications had higher MISS scores. 
• Limitation: Since participants may have higher adherence to 
SMBG compared to general diabetes patients (volunteer bias), it 
would be harder to find an effect for invasiveness as a barrier to 
SMBG.  
 
Nagelkerk J 
et al. (2006)27 
• Perceived barriers to self-management in rank order 
1. Lack of knowledge and understanding of a specific diet plan 
2. Lack of individualized and coordinated care 
3. Helplessness and frustration from lack of glycaemic control despite adherence 
4. Limited resources to obtain recommended equipment, medicines, laboratory tests and 
provider services 
5. Inconvenient, costly and non-specific group education sessions 
6. Difficulty in remembering to take medications, lack of knowledge about medication 
action, side effects, schedules, and adjustments 
• Limitation: 1) one clinical practice with a fairly homogeneous 
sample, and 2) no causal inference due to cross-sectional study. 
• Identifying individual barriers, facilitating the acquisition of a 
support network, developing collaborative relationships with 
healthcare providers and maintaining a positive attitude are key 
strategies in facilitating integration. 
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• Effective strategies in self-management by rank order 
1. Developing a collaborative relationship with a healthcare provider 
2. Maintaining a positive attitude that prompts proactive learning 
3. Having a support person who gives encouragement and assistance and facilitates self-
management 
4. Acquiring adequate resources for self-management 
5. Maintaining routine medication administration times and routines 
6. Participating in group education that encourages questions and discussion of feelings 
and fears 
Morrow AS et 
al. (2008)13 
• Factors influencing diabetes self-care goals: Health care providers, ancillary and outside 
resources, family, diabetes discordant illnesses (barrier), and retirement (barrier). 
• Functional capabilities and social support were key factors in the ways that older adults 
described the relationship between self-management of diabetes and their broader goals. 
• Limitation: 1) generalizability 
Daly JM et 
al. (2009)28 
• The main barriers across most self-care behaviors were cost (most common) and 
depression. 
• Higher HbA1c levels were strongly associated with the belief that type 2 diabetes is a 
serious problem (P = 0.049) and depression (P = 0.005). Lower HbA1c levels were 
significantly associated with being married (P = 0.016) and greater self-reported 
adherence-satisfaction with taking medication (P = 0.001) and testing blood glucose (P 
= 0.042). 
• The PHQ-9 depression score was significantly correlated with financial barriers, with a 
coefficient of 0.45 (P = 0.0001). In the t test, PHQ-9 mean score was 11.51 for people 
with financial barriers compared with 5.33 for those without financial barriers (P = 
0.0001). 
• Limitation: 1) small sample size,  2) no causal inference due to 
cross-sectional study, 3) self-report measurement 
 
SMBG: Self-Monitoring of Blood Glucose 
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Table 5: Characteristics of studies investigating effects of depression on self-care behaviors in people with diabetes 
AUTHOR 
STUDY 
DESIGN 
STUDY AIM POPULATION 
SAMPLE 
SIZE 
DEPRESSION 
ASSESSMENT 
SELF-CARE ASSESSMENT 
Ciechanowski 
PS et al. 
(2000)37  
Cross-
sectional study 
To explore the impact 
of depressive 
symptoms in primary 
care patients with 
diabetes on diabetes 
self-care, adherence 
to medication 
regimens, 
functioning, and 
health care costs. 
Patients from 2 primary care 
clinics of the Group Health 
Cooperative (GHC) in Puget 
Sound, Washington. 
Inclusion: types 1 and 2 
diabetes, > 18 years old, and 
≥ 2 years enrollment.  
Exclusion
367 subjects  
: severe cognitive 
deficit. 
Hopkins Symptom 
Checklist-20, Revised  
(HSCL-20)  
• 20-item questionnaire 
• Depression and 
additional symptom 
subscales 
• 3 tertiles of depression: 
low, medium, and high 
• Self-report 
Diet (amount and type), exercise, and 
SMBG 
• 12-item questionnaire 
• Percentage of activities 
recommended by the physician that 
were actually performed. 
• Self-report 
Adherence to oral hypoglycemic 
regimens 
• Automated data 
• Percentage of days in oral 
hypoglycemic therapy interruption 
Ciechanowski 
PS et al. 
(2003)38 
Cross-
sectional study 
To determine if 
diabetes self-care 
behaviors, physical 
functioning, diabetes 
symptom reporting, 
and glucose control 
are significantly 
associated with 
depressive symptoms 
in both type 1 and 2 
diabetes. 
This study was carried out in a 
tertiary care specialty clinic at 
the University of Washington 
Diabetes Care Center (DCC), 
Seattle, Washington.  
Inclusion
Exclusion: severe cognitive 
deficits 
: type 1 or type 2 
diabetes, enrollment in both 
1998 and 1999, ≥ 18 years 
old  
Type 1 = 
276 subjects 
Type 2 = 
199 subjects 
Hopkins Symptom 
Checklist-20, Revised  
(HSCL-20)  
• 20-item questionnaire 
• Depression and 
additional symptom 
subscales 
• Self-report 
Diet (amount and type), exercise, and 
SMBG 
• 12-item questionnaire 
• Percentage of activities 
recommended by the physician that 
were actually performed. 
• Self-report 
 
Lin EH et al. 
(2004)39 
Cross-
sectional study 
To assess whether 
diabetes self-care, 
medication 
adherence, and use of 
preventive services 
were associated with 
depressive illness. 
Nine Group Health 
Cooperative primary care 
clinics in western Washington 
were selected for the study. 
Inclusion: type 1 or type 2 
diabetes  
Exclusion: cognitive 
impairment 
4463 
subjects 
(Type 1 = 
95.6% 
Type 2 = 
4.4%) 
Patient Health 
Questionnaire 
• According to DSM-IV 
criteria 
• A continuous severity 
score.  
• Structured interviews 
(78% sensitivity and 
98% specificity). 
• Self-report 
Diet, exercise, SMBG, foot checks, and 
smoking status 
• Recently revised version of the 
Summary of Diabetes Self-Care 
Activities (SDSCA) 
• Number of days in the prior week 
subject engaged in a certain activity 
• Self-report 
Adherence to oral hypoglycemic 
medicines 
• GHC automated pharmacy database 
• Percentage of non-adherence days  
Preventive services (HbA1c test, retinal 
exam, and microalbumin urine test) 
30 
• Automated diagnostic and 
laboratory data 
Park HS et al. 
(2004)40 
Cross-
sectional study 
To determine whether 
depressive symptoms 
are associated with 
poor self-care 
behaviors among 
people with type 2 
diabetes 
People who visited the Ewha 
Womans University Hospital, 
Seoul, Republic of Korea,  
Inclusion: type 2 diabetes 
history of 1-15 years, and > 
30 years old. 
Exclusion: Advanced 
diabetic complications, or a 
history of psychiatric 
treatment. 
168 subjects Centers for Epidemiologic 
Studies-Depression (CES-
D) scales. 
• Self-report 
 
Medication adherence, SMBG, diet, 
exercise, and participation in patient 
education programs 
• Self-report 
• Dichotomized into adherent or non-
adherent categories. 
Kilbourne AM 
et al. (2005)43 
Prospective 
cohort study 
To assessed the 
association between 
depression and 
diabetes medication 
adherence  
 
Veterans receiving primary 
care at an urban Veterans 
Administration facility in US 
Inclusion: type 2 diabetes, 
and taking oral 
hypoglycemic therapy 
medication 
Exclusion:  taking insulin 
only 
203 subjects Patient Health 
Questionnaire (PHQ-9) 
• At baseline 
• Self-report 
• The presence of the 
nine symptoms of 
depression 
corresponding to 
DSM-IV criteria 
• Dichotomized variable 
(sensitivity = 0.73 and 
specificity = 0.94) 
Adherence to oral hypoglycemic 
therapy 
• Four sources: patient report, 
provider report, electronic 
monitoring caps (EMCs), and 
pharmacy data 
 
 
Kalsekar ID 
et al. (2006)42 
Retrospective 
cohort study 
To examine the 
impact of depression 
on adherence to oral 
hypoglycemic agents 
in people newly 
diagnosed with type 2 
diabetes 
People newly diagnosed with 
type 2 diabetes during a 4 year 
period (1998-2001) were 
identified from a Medicaid 
claims database. 
Exclusion: ≥ 65 years old, 
people who took 
troglitazone, people with 
schizophrenia, bipolar 
disorder, dementia, and 
Alzheimer’s disease 
1326 
subjects 
Medical claim data 
• Single-episode major 
depressive disorder 
(ICD-9-CM codes 
296.20-296.26), 
recurrent-episode 
major depressive 
disorder (ICD -9-CM 
code 296.3), neurotic 
depression/ chronic 
depression /dysthymia 
(ICD -9-CM code 
300.4), and depression 
not otherwise specified 
(ICD -9-CM code 
311). 
Adherence to oral hypoglycemic agents 
• Prescription refill data 
• 12 month follow-up period from the 
index prescription  
• MPR-1: a measure of medication 
adherence in the period between the 
first and last prescription fills  
• MPR-2: a measure of medication 
adherence in the period between the 
index prescription and the end of the 
follow-up period. People who 
discontinued therapy after a single 
prescription were included 
Gonzalez JS 
et al. (2007)41 
Cross-
sectional study 
To examine the 
association between 
People who were followed in 
one of two outpatient primary 
879 subjects Harvard Department of 
Psychiatry/National 
Diet, exercise, SMBG, and foot care 
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depression, measured 
as either a continuous 
symptom severity 
variable or a clinical 
categorical variable, 
and self-care 
behaviors in type 2 
diabetes. 
care medical clinics in 
Massachusetts 
Inclusion: type 2 diabetes, 
and at least one primary care 
visit 
Depression Screening Day 
Scale (HANDS) 
• 10-item questionnaire 
• Total score: 0 to 30 
• A score of ≥ 9 for 
depression (sensitivity 
> 0.95 and specificity 
= 0.60–0.94) 
• Self-report  
• Recently revised version of the 
Summary of Diabetes Self-Care 
Activities (SDSCA) 
• Number of days of non–adherence 
over the previous 7 days 
• Self-report 
Medication adherence 
• Self-report 
• Dichotomized responses into “any 
missed doses” and “no missed 
doses” in the past 7 days 
SMBG: Self-Monitoring Of Blood Glucose 
MPR: Medication Possession Ratio 
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Table 6: Major findings of studies investigating effects of depression on self-care behaviors in people with diabetes 
AUTHOR 
MAJOR FINDING(S) / RESULTS (PRIMARILY WITH RESPECT TO 
DEPRESSION) 
STUDY NOVELTY / COMMENTS 
Ciechanowski 
PS et al. 
(2000)37 
• Compared with people in the low-severity depression symptom tertile, those in the 
medium- and high severity tertiles of depression were significantly less adherent to 
dietary recommendations (diet amount or diet type). 
• People in the high-severity tertile were significantly distinct from those in the low 
severity tertile by having a higher percentage of days in non-adherence to oral 
hypoglycemic regimens (7.1% vs. 14.9%, P = 0.04). 
• There is no effect of depression on exercise and glucose monitoring. 
• This study was probably the first one investigating the association 
between depression and self-care behaviors. 
• The severity of depression was divided into four level: none, low, 
medium, and high 
Ciechanowski 
PS et al. 
(2003)38 
• Among people with type 1 and 2 diabetes, depressive symptoms were significantly 
associated with lower adherence to diet amount (P < 0.001), diet type (P < 0.05), and 
exercise regimens (P < 0.01), but not significantly associated with glucose monitoring.  
• These associations were robust after controlling for diabetes type 
and complications. 
• This study was conducted in a tertiary care specialty clinic, which 
may limit the generalizability to a typical primary care population.  
Lin EH et al. 
(2004)39 
• Major depression was associated with unhealthy diet, less physical activity, smoking, 
and lower adherence to oral hypoglycemic, antihypertensive, and lipid-lowering 
medications.  
• A slightly higher proportion of people with depression received no HbA1c test in the 
prior year compared to those without depression. 
• Depressed people and non-depressed people did not significantly differ from each other 
with regard to home-glucose tests, foot checks, and other preventive diabetes services. 
• Depression appeared to influence patient-initiated activities (e.g., 
exercise, diet, and medication adherence) more than physician-
initiated services (e.g., HbA1c test, retinal test, and microalbumin 
test). 
Park HS et 
al. (2004)40 
• Higher depressive-symptom scores were significantly associated with poor participation 
in education programs (OR = 1.21, 95% CI = 1.06–1.38), poor diet (OR = 1.11, 95% CI 
= 1.01–1.22), and marginally with poor medication taking (OR = 1.14, 95% CI = 1.00–
1.31). 
•  Depressive symptoms were not significantly associated with either SMBG or exercise. 
• This study was the only one conducted in Korea. 
• This study also investigated the association between depression 
and participation in education programs, which is one of the most 
important behaviors for diabetes care. 
• The lower rates of glucose monitoring in this study can be 
explained by cost for glucometers, which was not covered by 
insurance in Korea.  
Kilbourne 
AM et al. 
(2005)43 
• Depressed people were less likely to self-report good adherence (P = 0.03) and had a 
lower median percentage of days with adequate medication coverage on the basis of 
pharmacy refill data.  
• After adjustment for alcohol use, cognitive impairment, age, and other medication use, 
depression was still negatively associated with adequate adherence according to patient 
report and pharmacy data.  
• Depression showed no association with medication adherence on the basis of provider 
or EMC data. 
• The generalizability of this study was limited because 1) the VA 
healthcare system had unique features, such as the mail-order 
pharmacy system and a comprehensive pharmacy database 2) it 
only included the elder veteran population without female people. 
Kalsekar ID 
et al. (2006)42 
• People with depression had significantly lower adherence (MPR-1 86%; MPR-2 66%) 
to oral hypoglycemic agents compared with people without depression (MPR-1 89%; 
MPR-2 73%).  
• Depressed people were 3–6% less adherent to oral hypoglycemic agents than non-
• This study only recruited younger people with newly diagnosed 
type 2 diabetes. 
• The magnitude of difference in adherence was not large in this 
study. 
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depressed people, after controlling for confounding factors. 
Gonzalez JS 
et al. (2007)41 
• After controlling for covariates, people with probable major depression reported 
significantly fewer days’ adherent to diet, exercise, and glucose self-monitoring 
regimens (P ＜ 0.01) and 2.3-fold increased odds of missing medication doses in the 
previous week (95% CI 1.5–3.6, P ＜ 0.001) compared with all other respondents.  
• Among the two-thirds of people not meeting the criteria for major depression (HANDS 
score ＜ 9, n = 709), increasing HANDS scores were incrementally associated with 
poorer self-care behaviors (P ＜ 0.01). 
• These findings challenged the conceptualization of depression as 
a categorical risk factor for non-adherence.  
• Even low levels of depressive symptomatology were associated 
with non-adherence to important aspects of diabetes self-care. 
SMBG: Self-Monitoring Of Blood Glucose 
MPR: Medication Possession Ratio 
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Table 7: Characteristics of studies investigating depression treatment in people with diabetes and depression 
AUTHOR 
STUDY 
DESIGN 
STUDY AIM POPULATION SAMPLE SIZE MEASUREMENTS 
Lustman 
PJ et al. 
(1997)48 
Randomized 
controlled 
trials 
To evaluate the effects of 
nortriptyline on 
depression and glycemic 
control to see whether 
depression in diabetes is 
treatable and whether 
restoring mental health 
contributes to improved 
medical outcome. 
 
Intervention: nortriptyline 
Control: placebo 
Inclusion: 21 to 65 y/o, type 1 or 
type 2 diabetes, and relatively poor 
control of diabetes (HbA1c ≥ 9%) 
Exclusion: having history of bipolar 
depression or any psychotic 
disorder, and currently taking 
psychoactive medications. 
 
 
28 depressed 
subjects (14 
subjects in 
nortriptyline 
group and 14 
subjects in 
placebo group); 
40 non-depressed 
subjects (12 
subjects in 
nortriptyline 
group and 28 
subjects in 
placebo group) 
 
Depression:  
• The major Axis I clinical syndromes were assessed 
using the DIS (revised three version) and diagnosed 
according to the criteria of the DSM-IIIR 
• The severity of current depression symptoms was 
measured using the BDI 
Diabetes outcome: 
• HbA1c 
Adherence to medication: 
• An electronic monitoring device was used 
• Adherence = (the number of days the patient 
removed the prescribed number of medication 
dosages) ÷ (the total number of days in treatment) 
Adherence to self-monitoring of blood glucose: 
• An memory glucometer was used 
• Weekly adherence = (the number of samples 
measured) ÷ (the number of tests requested)  
Lustman 
PJ et al. 
(1998)49 
Randomized 
controlled 
trials 
To determine the 
antidepressant efficacy of 
cognitive behavior 
therapy (CBT) added to 
supportive diabetes 
education, and whether 
remission of depression is 
associated with improved 
glycemic control. 
 
Intervention: CBT plus 
diabetes education 
Control: diabetes 
education 
Inclusion: type 2 diabetes, 21 to 70 
y/o, and major depression 
Exclusion: having a history of panic 
disorder, bipolar depression, or any 
psychotic disorder, currently taking 
psychoactive medications. 
 
Depression Identification: ≥ 14 on 
BDI 
20 subjects 
receiving CBT 
plus diabetes 
education; 22 
subjects receiving 
diabetes alone 
 
Depression:  
• The major Axis I clinical syndromes were assessed 
using the DIS (revised three version) and diagnosed 
according to the criteria of the DSM-IIIR 
• The severity of current depression symptoms was 
measured using the BDI 
Adherence to self-monitoring of blood glucose: 
• An memory glucometer was used 
• Weekly adherence = (the number of samples 
measured) ÷ (the number of tests requested) 
Williams 
JW et al. 
(2004)50 
Randomized 
controlled 
trials 
To determine whether 
enhancing care for 
depression improves 
affective and diabetic 
outcomes in older adults 
with diabetes and 
depression. 
Inclusion: ≥ 60 y/o, type 1 or type 2 
diabetes, and major depression or 
dysthymic disorder 
Exclusion: having a history of 
bipolar disorder or psychosis, 
ongoing treatment with a 
psychiatrist, or  severe cognitive 
205 subjects in 
intervention 
group; 212 
subjects in usual 
group 
Depression:  
• The severity of depressive symptoms were assessed 
using the SCL-20 
• The diagnoses of major depression or dysthymia 
were evaluated using the structured clinical 
interview for DSM-IV 
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Intervention: enhanced 
depression care 
(education, problem 
solving, and 
antidepressant) 
Control: usual care 
impairment 
 
Depression Identification: 
According to the criteria of the 
DSM-IV 
 
Diabetes self-care (diet, exercise, glucose testing, 
diabetes medication, and foot care): 
• The 12-item SDSCA, augmented by an item to 
assess foot care 
Diabetes outcome: 
• HbA1c 
Lin EH et 
al. 
(2006)46 
Randomized 
controlled 
trials 
To examine the impact of 
improved depression 
treatment on self-care 
behaviors 
 
Intervention: improved 
depression care 
(pharmacotherapy and/or 
problem solving) 
Control: usual care 
 
 
Inclusion: ≥ 18 y/o, diagnosed with 
type 1 or type 2 diabetes and 
depression 
Exclusion: having gestational 
diabetes, psychotic disorder, bipolar 
disorder, use of mood-stabilizing or 
antipsychotic medication, and 
current care by a psychiatrist 
 
Depression Identification: A score 
of 10 or higher on the PHQ-9  at the 
initial screening and evidence of 
persistent depression as measured 
by a mean item score of 1.1 or 
higher on the SCL-20 2 weeks later. 
164 subjects in 
intervention 
group; 165 
subjects in usual 
group 
Diet, exercise, blood glucose testing, foot checks, and 
smoking 
• The 12-item SDSCA  
Medication adherence 
• Automated pharmacy refill data of oral 
hypoglycemic agents, lipid-lowering agents, and 
angiotensin-converting enzyme inhibitors 
DIS: National Institute of Mental Health Diagnostic Interview Schedule  
DSM: Diagnostic and Statistical Manual of Mental Disorders 
BDI: Beck Depression Inventory 
PHQ-9: Patient Health Questionnaire-9 
SCL-20: Hopkins Symptom Checklist-20 
SDSCA: Summary of Diabetes Self-Care Activities 
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Table 8: Major findings of studies investigating depression treatment in people with diabetes and depression 
AUTHOR 
MAJOR FINDING(S) / RESULTS (PRIMARILY WITH RESPECT TO 
DEPRESSION) 
STUDY NOVELTY / COMMENTS 
Lustman PJ 
et al. (1997)48 
• The reduction in depression symptoms was significantly greater in depressed people 
treated with nortriptyline compared with those receiving placebo (-10.2 vs -5.8, p = .03).  
• Nortriptyline was not statistically superior to placebo in reducing glycated hemoglobin 
of the depressed subjects (p = .5).  
• For people in the nortriptyline and placebo groups, the compliance with the medication 
regimen and with blood glucose monitoring did not differ as a function of treatment 
received during the 8-week trial. 
• Path analysis indicated that the direct effect of nortriptyline was to worsen glycemic 
control whereas depression improvement had an independent beneficial effect on 
glycated hemoglobin. These findings were not explained by the relationships of 
nortriptyline treatment to weight change (r = -0.21, p = .31) or depression improvement 
to compliance with the protocol for self-monitoring of blood glucose (r = 0.01, p = .97). 
• The HbA1c level cannot appropriately be used to evaluate the 
effects of treatment on glucose control during the study (8 weeks) 
since this measurement reflects average blood glucose levels over 
the preceding 90-120 days. 
 
Lustman PJ 
et al. (1998)49 
• The percentage of people achieving remission of depression (Beck Depression 
Inventory score ≤ 9) was greater in the CBT group than in the control group: post- 
treatment, 85.0% of people in the CBT group compared with 27.3% of controls 
achieved remission (difference, 57.7 percentage points [95% Cl, 33 to 82 percentage 
points]) (P< 0.001); at follow-up, 70.0% of people in the CBT group compared with 
33.3% of controls  achieved remission (difference, 36.7 percentage points [Cl, 9 to 65 
percentage points]) (P = 0.03).  
• Post-treatment glycosylated hemoglobin levels were not different in the two groups, but 
follow-up mean glycosylated hemoglobin levels were significantly better in the CBT 
group than in the control group (9.5% compared with 10.9%; P= 0.03). 
• Covariate-adjusted mean GHb levels were lower in the nondepressed group at both the 
post-treatment (8.5% compared with 10.9%; P = 0.003) and follow- up (9.2% compared 
with 12.1%; P = 0.006) evaluations compared to depressed group at the both time 
points. 
• Over the 10-week treatment period, compliance with self-monitoring of blood glucose 
levels declined in the CBT group compared with the control group (P = 0.01). 
• The explanation for decreased adherence to glucose monitoring in 
CBT group may be that participation of the CBT group in diabetes 
education complicated an already complex regimen and was more 
than the people could handle. It is a well-established principle of 
compliance that any action that complicates a treatment regimen 
(such as adding a medication or using divided rather than single-
dose schedules) usually decreases compliance with other 
components of treatment. 
 
Williams JW 
et al. (2004)50 
• At 12 months, diabetic patients who were assigned to intervention had less severe 
depression (range, 0 to 4 on a checklist of 20 depression items; between-group 
difference, –0.43 [95% CI, –0.57 to –0.29]; P < 0.001) than did participants who 
received usual care. 
• In the intervention group, weekly exercise days increased (between-group difference, 
0.50 day [CI, 0.12 to 0.89 day]; P = 0.001); other self-care behaviors were not affected. 
• At baseline, mean (±SD) hemoglobin A1c levels were 7.28% ± 1.43%; follow-up values 
were unaffected by the intervention (P > 0.2). 
• In this study, subjects were significantly older, less likely to 
receive hypoglycemic medications, and had much better mean 
hemoglobin A1c levels at baseline than did subjects in other 
studies.  
 
Lin EH et al. • During the 12-month intervention period, enhanced depression care and outcomes were • Perhaps 1) the seemingly logical assumption reflects too 
37 
(2006)46 not associated with improved diabetes self-care behaviors (healthy nutrition, physical 
activity, or smoking cessation).  
• Relative to the usual care group, the intervention group reported a higher rate of 
nonadherence to oral hypoglycemic agents (mean difference = –6.3%, 95% CI, –11.91% 
to –0.71%). Adherence to lipid-lowering agents and to antihypertensive medicines was 
similar for the 2 groups. 
simplistic an understanding of the relation between depression 
and behavior changes or/and 2) the modest effects of the 
intervention on depression outcomes may not have been powerful 
enough to increase optimism and motivation, prerequisites for 
good self-care. 
• Intervention patients showed lower adherence to oral 
hypoglycemic medicines may highlights the complexity and 
challenge people face in managing multiple medical conditions on 
a daily basis. 
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Non-depression = 507 
Depression = 271 
Total = 778 
Non-depression (self-report) = 1089 
Depression (self-report) = 435 
Total = 1524 
Non-depression = 687 
Depression = 350 
Total = 1037 
Patients with Type 2 Diabetes 
Non-depression (self-report) = 1089 
Depression (self-report) = 435 
Missing = 51  
Total = 1575 
 
Remove missing data in self-report depression = 51 
Remove missing data in any behavior change goal = 367 
Remove missing data in any barrier = 259 
Correct misclassification = 84 (based on antidepressant 
use) 
Remove missing data in antidepressant use = 120 
Non-depression (self-report) = 1005 
Depression (self-report) = 399 
Total = 1404 
Non-depression = 1005 – 84 = 921 
Depression = 399 + 84 = 483 
Total = 1404 
Figure 1: Flowchart of patients in this analysis 
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Table 9: Demographic and clinical characteristics of patients with type 2 diabetes by depression/antidepressant status 
 Non-depression (n = 507) 
Depression with 
Antidepressant 
(n = 181) 
Depression 
without 
Antidepressant 
(n = 90) 
No. of 
Missing 
Value 
P valuea P valueb 
Age,  median (q1-
q3),y 60 (52 – 69) 55 (49 – 62) 57 (49 – 70) 0, 0, 1 <.0001 0.04 
BMI,  median (q1-
q3), kg/m2 
33.16 (28.78–
39.14) 
34.75 (30.90–
40.14) 
33.03 (28.37–
39.49) 
46, 30, 
11 0.03 0.14 
Gender, N (%) 
 Men 228 (44.97) 49 (27.07) 27 (30.00) 
0 <.0001 0.61 
 Women 279 (55.03) 132 (72.93) 63 (70.00) 
Race, N (%) 
 White 437 (86.71) 155 (85.64) 76 (86.36) 
3, 0, 2 0.79 0.96  Black 41 (8.13) 14 (7.73) 7 (7.95) 
 Others 26 (5.16) 12 (6.63) 5 (5.68) 
Educational status, N (%) 
 Did not finish high school 59 (11.68) 21 (11.67) 6 (6.67) 
2, 1, 0 0.66 0.35  High school 232 (45.94) 84 (46.67) 48 (53.33) 
 Some college or greater 214 (42.38) 75 (41.67) 36 (40.00) 
Smoking, N (%) 
 Never 324 (76.78) 109 (68.99) 49 (63.64) 
85, 23, 
13 0.01 0.64  Former 21 (4.98) 7 (4.43) 3 (3.90) 
 Current 77 (18.25) 42 (26.58) 25 (32.47) 
Alcohol drinking, N 
(%) 134 (26.64) 35 (19.34) 20 (22.47) 4, 0, 1 0.05 0.55 
Family history of 
diabetes, N (%) 365 (72.71) 140 (78.65) 67 (74.44) 5, 3, 0 0.17 0.44 
Years with diabetes, 
median (q1-q3) 2 (0–10) 3 (0–10) 1 (0–9) 
91, 36, 
15 0.84 0.17 
Diabetes education, 
N (%) 120 (23.81) 53 (29.44) 13 (14.44) 3, 1, 0 0.84 0.007 
HbA1c, median (q1-
q3),% 7.7 (6.7–9.3) 7.7 (6.8–9.3) 7.7 (6.7–9.5) 
168, 51, 
25 0.80 0.80 
Complications, N (%) 
 High blood pressure 355 (70.02) 131 (72.38) 58 (64.44) 0 0.94 0.18 
 Stroke 22 (4.34) 11 (6.08) 6 (6.67) 0 0.24 0.85 
 Heart disease / Chest pain 140 (27.61) 50 (27.62) 30 (33.33) 0 0.57 0.33 
 
Kidney / 
Bladder 
problems 
76 (14.99) 43 (23.76) 18 (20.00) 0 0.009 0.49 
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 Numbness / Pain 
/ Tingling of 
hands/feet 
200 (39.45) 88 (48.62) 50 (55.56) 0 0.002 0.28 
 Eye or vision problems 155 (30.57) 75 (41.44) 45 (50.00) 0 0.0001 0.18 
 Problems with sexual function 75 (14.79) 31 (17.13) 17 (18.89) 0 0.29 0.72 
No. of 
complications, 
median (q1-q3) 
2 (1–3) 2 (1–3) 2 (1–3) 0 0.0002 0.58 
With any 
complication, N (%) 468 (92.31) 171 (94.48) 83 (92.22) 0 0.47 0.47 
With ≥ 3 
complications, N 
(%) 
160 (31.56) 79 (43.65) 44 (48.89) 0 0.0001 0.41 
Insulin, N (%) 128 (25.25) 58 (32.04) 22 (24.44) 0 0.20 0.20 
aThe P value is used to make comparisons between patients with and without depression. For categorical 
variables, the P value is generated from the χ2 test. For continuous variables, the P value is generated from the 
Wilcoxon rank sum test since all the variables are not normally distributed. 
bThe P value is used to make comparisons between patients with and without antidepressant in the depressed 
subgroup. For categorical variables, the P value is generated from the χ2 test. For continuous variables, the P 
value is generated from the Wilcoxon rank sum test since all the variables are not normally distributed. 
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Table 10: Self-identified behavior change goals of patients with type 2 diabetes by depression/antidepressant status 
 
Non-
depression 
(n = 507) 
Depression 
with 
Antidepressant 
(n = 181) 
Depression 
without 
Antidepressant 
(n = 90) 
P valuea P valueb 
No. of self-identified behavior 
change goals, median (q1-q3) 2 (1 – 4) 2 (1 – 4) 2 (1 – 3) 0.11 0.26 
Activity, N (%) 265 (52.27) 111 (61.33) 48 (53.33) 0.09 0.21 
Eating, N (%) 370 (72.98) 139 (76.80) 64 (71.11) 0.56 0.31 
Medication taking, N (%) 90 (17.75) 34 (18.78) 20 (22.22) 0.46 0.50 
Monitoring, N (%) 112 (22.09) 46 (25.41) 22 (24.44) 0.34 0.86 
Problem solving for blood sugars 
and sick days, N (%) 81 (15.98) 42 (23.20) 17 (18.89) 0.05 0.42 
Reducing risks of diabetes 
complications, N (%) 252 (49.70) 89 (49.17) 38 (42.22) 0.45 0.28 
Living with diabetes, N (%) 170 (33.53) 70 (38.67) 30 (33.33) 0.35 0.39 
aThe distributions between patients with and without depression are compared using the χ2 tests for 
categorical variables and the Wilcoxon rank sum test for continuous variables since the number of behavior 
change goals is not normally distributed. 
bThe distributions between patients with and without antidepressant in the depressed subgroup are compared 
using the χ2 tests for categorical variables and the Wilcoxon rank sum test for continuous variables since the 
number of behavior change goals is not normally distributed. 
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Table 11: Barriers to diabetes self-care of patients with type 2 diabetes by depression/antidepressant status 
 
Non-
depression 
(n = 507) 
Depression 
with 
Antidepressant 
(n = 181) 
Depression 
without 
Antidepressant 
(n = 90) 
P valuea P valueb 
No. of barriers, median (q1-q3) 6 (3 – 8) 7 (5 – 10) 7 (5 – 9) <.0001 0.75 
I don't know what to do or how 
to do it, N (%) 405 (79.88) 155 (85.64) 77 (85.56) 0.05 0.99 
It's too hard, N (%) 330 (65.09) 134 (74.03) 70 (77.78) 0.004 0.50 
I don't have the time, N (%) 282 (55.62) 101 (55.80) 52 (57.78) 0.82 0.76 
My health is not good, N (%) 264 (52.07) 123 (67.96) 62 (68.89) <.0001 0.88 
I can't see well enough to do it, N 
(%) 99 (19.53) 46 (25.41) 30 (33.33) 0.007 0.17 
I can't afford it, N (%) 201 (39.64) 98 (54.14) 40 (44.44) 0.003 0.13 
No place to do it, N (%) 132 (26.04) 57 (31.49) 23 (25.56) 0.30 0.31 
I don't have the will power, N 
(%) 317 (62.52) 142 (78.45) 63 (70.00) 0.0002 0.13 
My family / friends don't support 
me, N (%) 153 (30.18) 76 (41.99) 30 (33.33) 0.01 0.17 
I can't remember to do it, N (%) 190 (37.48) 88 (48.62) 39 (43.33) 0.01 0.41 
It's too uncomfortable, N (%) 198 (39.05) 93 (51.38) 41 (45.56) 0.005 0.37 
It's not that important, N (%) 117 (23.08) 48 (26.52) 26 (28.89) 0.19 0.68 
I don't enjoy it, N (%) 299 (58.97) 114 (62.98) 60 (66.67) 0.15 0.55 
aThe distributions between patients with and without depression are compared using the χ2 tests for categorical 
variables and the Wilcoxon rank sum test for continuous variables since the number of barriers is not normally 
distributed. 
bThe distributions between patients with and without antidepressant in the depressed subgroup are compared 
using the χ2 tests for categorical variables and the Wilcoxon rank sum test for continuous variables since the 
number of barriers is not normally distributed. 
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Table 12: Multivariable Models 
Model 1: Association between depression and  the number of goals (n = 769) Adjusted R-Square = 0.0789 
Variables Coefficient Estimate P value 95% Confidence Interval 
Depression (yes/no) 0.10 0.47 (-0.16, 0.35) 
Age (year) -0.02 <.0001 (-0.03, -0.01) 
Race (ref = White)    
Black  -0.56 0.02 (-1.01, -0.10) 
Others  -0.68 0.01 (-1.22, -0.15) 
Educational status (ref = Some college or 
greater)    
Did not finish high school  -0.88 <.0001 (-1.30, -0.46) 
High school diploma -0.51 0.0002 (-0.77, -0.25) 
No. of barriers (7-13/0-6) 0.28 0.03 (0.04, 0.53) 
 
Model 2: Association between depression and  the number of barriers (n = 683) Adjusted R-Square = 0.1166 
Variables Coefficient Estimate P value 95% Confidence Interval 
Depression (yes/no) 1.01 0.0001 (0.50, 1.52) 
BMI (kg/m2) 3.40 <.0001 (2.26, 4.54) 
Race (ref = White)    
Black  0.92 0.05 (0.01, 1.83) 
Others  1.70 0.006 (0.50, 2.90) 
Educational status (ref = Some college or 
greater)    
Did not finish high school  1.11 0.01 (0.27, 1.95) 
High school diploma 0.41 0.11 (-0.10, 0.92) 
Age (year) -0.009 0.38 (-0.03, 0.01) 
Insulin (yes/no) 1.10 <.0001 (0.56, 1.65) 
 
Model 3A: Association between antidepressant use and  the number of goals in the 
depressed subgroup (n = 264) Adjusted R-Square = 0.0854 
Variables Coefficient Estimate P value 95% Confidence Interval 
Antidepressant (yes/no) 0.31 0.18 (-0.15, 0.77) 
Age (year) -0.01 0.17 (-0.03, 0.006) 
Race (ref = White)    
Black  -0.82 0.04 (-1.62, -0.02) 
Others  -1.43 0.001 (-2.31, -0.56) 
Educational status (ref = Some college or 
greater)    
Did not finish high school  -0.74 0.05 (-1.49, 0.01) 
High school diploma -0.36 0.13 (-0.82, 0.10) 
Insulin (yes/no) -0.43 0.07 (-0.91, 0.04) 
Family history of diabetes (yes/ no) 0.49 0.06 (-0.03, 1.02) 
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Model 3B: Association between antidepressant use and  the number of goals in the 
depressed subgroup (n = 268) Adjusted R-Square = 0.0539 
Variables Coefficient Estimate P value 95% Confidence Interval 
Antidepressant (yes/no) 0.22 0.35 (-0.24, 0.68) 
Age (year) -0.02 0.02 (-0.04, -0.004) 
Race (ref = White)    
Black  -0.79 0.05 (-1.59, 0.01) 
Others  -1.34 0.003 (-2.23, -0.46) 
 
Model 4: Association between antidepressant use and  the number of barriers in the 
depressed subgroup (n = 228) Adjusted R-Square = 0.0955 
Variables Coefficient Estimate P value 95% Confidence Interval 
Antidepressant (yes/no) 0.005 0.99 (-0.85, 0.86) 
Age (year) 0.01 0.52 (-0.02, 0.05) 
BMI (Kg/m2) 3.71 0.0003 (1.74, 5.68) 
Educational status (ref = Some college or 
greater)    
Did not finish high school  1.53 0.04 (0.08, 2.99) 
High school diploma 0.52 0.24 (-0.34, 1.38) 
Insulin (yes/no) 1.38 0.004 (0.45, 2.30) 
Table 12: Multivariable Models (cont.) 
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APPENDIX A: DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF 
PATIENTS IN STUDY AND OUT OF STUDY 
 Out of Study (n = 797) 
In Study 
(n = 778) 
No. of 
Missing 
P 
valuea 
Depression status, N (%) 212 (33.87) 271 (34.83) 171, 0 0.70 
Age,  median (q1-q3), y 60 (51–69) 58 (51–68) 6, 1 0.17 
BMI,  median (q1-q3), kg/m2 32.84 (28.15–38.20) 
33.67 (29.32–
39.42) 164, 87 0.02 
Gender, N (%) 
 Men 343 (43.04) 304 (39.07) 
0 0.11 
 Women 454 (56.96) 474 (60.93) 
Race, N (%) 
 White 647 (81.69) 668 (86.42) 
5, 5 0.03  Black 78 (9.85) 62 (8.02) 
 Others 67 (8.46) 43 (5.56) 
Educational status, N (%) 
 Did not finish high school 95 (12.55) 86 (11.10) 
40, 3 0.18  High school 379 (50.07) 364 (46.97) 
 Some college or greater 283 (37.38) 325 (41.94) 
Smoking, N (%) 
 Never 534 (76.83) 482 (73.36) 
102, 
121 0.32  Former 31 (4.46) 31 (4.72) 
 Current 130 (18.71) 144 (21.92) 
Alcohol drinking, N (%) 241 (30.98) 189 (24.45) 19, 5 0.004 
Family history of diabetes, N (%) 544 (69.74) 572 (74.29) 17, 8 0.05 
Years with diabetes, median (q1-q3) 1 (0–8) 2 (0–10) 186, 142 0.01 
Diabetes education, N (%) 166 (21.15) 186 (24.03) 12, 4 0.17 
HbA1c, median (q1-q3),% 7.5 (6.6–9.5) 7.7 (6.7–9.4) 316, 244 0.32 
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Complications, N (%) 
 High blood pressure 513 (68.77) 544 (69.92) 51, 0 0.62 
 Stroke 38 (5.09) 39 (5.01) 51, 0 0.94 
 Heart disease / Chest pain 188 (25.20) 220 (28.28) 51, 0 0.18 
 Kidney / Bladder problems 88 (11.80) 137 (17.61) 51, 0 0.001 
 Numbness / Pain / Tingling of hands/feet 260 (34.85) 338 (43.44) 51, 0 0.0006 
 Eye or vision problems 271 (36.33) 275 (35.35) 51, 0 0.69 
 Problems with sexual function 123 (16.49) 123 (15.81) 51, 0 0.72 
No. of complications, median (q1-
q3) 2 (1–3) 2 (1–3) 51, 0 0.005 
With any complication, N (%) 675 (90.48) 722 (92.80) 51, 0 0.10 
With ≥ 3 complications, N (%) 224 (30.03) 283 (36.38) 51, 0 0.009 
Insulin, N (%) 147 (21.88) 208 (26.74) 125, 0 0.03 
aFor categorical variables, the P value is generated from the χ2 test. Since all the continuous 
variables are not normally distributed, the P value is generated from the Wilcoxon rank sum 
test. 
 
47 
APPENDIX B: ANTIDEPRESSANT 
TCA (Tricyclic Antidepressant) 
Amitriptyline (Elavil) 
Nortriptyline (Pamelor) 
Imipramine (Tofranil) 
Desipramine (Norpramin) 
Clomipramine (Anafranil) 
Protriptyline (Vivactil) 
Lofepramine (Gamanil, Lomont) 
Trimipramine (Surmontil) 
Mianserin (Bolvidon) 
Doxepin (Sinequan) 
Amoxapine (Asendin) 
Dosulepin (Prothiaden) 
SSRI (Selective Serotonin Reuptake Inhibitor) 
Fluoxetine (Prozac) 
Paroxetine (Paxil) 
Sertraline (Zoloft) 
Fluvoxamine (Luvox) 
Citalopram (Celexa) 
Escitalopram (Lexapro) 
SNERI (Serotonin/Norepinephrine Reuptake Inhibitor) 
Reboxetine (Edronax) 
Venlafaxine (Effexor) 
Desvenlafaxine (Pristiq) 
Duloxetine (Cymbalta)  
Bupropion (Wellbutrin) 
Nafazodone or Nafezodone or Nefazodone (Serzone)  
Trazodone (Desyrel) 
Maprotiline (Ludiomil) 
Mirtazapine (Remeron) 
MAO (Monoamine Oxidase Inhibitor)  
Phenelzine (Nardil) 
Meclobemide (moclobemide) (Aurorix, Manerix) 
Selegiline (l-deprenyl) 
Tranylcypromine (Parnate) 
Isocarboxazid (Marplan) 
Miscellaneous  
St. John's wort 
Flupentixol or flupenthixol (Depixol and Fluanxol) 
Ademetionine (Gumbaral) 
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APPENDIX C: INSULIN 
Rapid-acting insulins 
Humalog (insulin lispro) 
Novolog (insulin aspart) 
Apidra (insulin glulisine) 
Short-acting insulins 
Humulin R (regular) 
Novolin R (regular) 
Intermediate-acting insulins 
NPH  
Humulin N 
Novolin N 
Lente 
Humulin L 
Long-acting insulins 
Humulin U (ultralente) 
Lantus (insulin glargine) 
Pre-mixed insulin 
Pre-mixed insulin analogs 
Humalog Mix 75/25 (insulin lispro) 
Novolog Mix 70/30 (insulin aspart) 
NPH-regular combinations 
Humulin 70/30 
Novolin 70/30 
Humulin 50/50 
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